TNF and rheumatoid arthritis: B cell therapy in RA aimed to reduce the production of pathogenic autoantibodies. If the patients suffer from incomplete responses to one previous TNF inhibitor, switching to rituximab is a better alternative to another TNF inhibitor [233].